Docencia
HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers (01-06-2017)
Dr. José Ramón Blanco. Investigador de la Unidad de VIH y Alteraciones Metabólicas Asociadas. Centro de investigación Biomédica de La Rioja
Eradication of HCV and non–liver-related non–AIDS-related events in HIV/HCV coinfection (16-05-2017)
Dra. Marisa Montes. Unidad de enfermedades infecciosas. Hospital Universitario de la Paz
Ischaemic stroke in HIV-infected pa:ents: a case–control study (28-04-2017)
Dr. Javier de la Torre Lima. Servicio de Medicina Interna. Hospital Costa del Sol. Marbella
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population (17-04-2017)
Dra. Concha Amador Prous. Médico de Enfermedades Infecciosas. Hospital Villajoyosa de Alicante
Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial (31-03-2017)
Dr. José A. Pérez Molina. Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal
High Rates of Anal High-Grade Squamous Intraepithelial Lesions in HIV-Infected Women Who Do Not Meet Screening Guidelines (15-03-2017)
Dr. Adrian Currán Atencion sanitaria y hospitalaria Hospital Universitari de la Vall d´Hebron
Immunological and infectious risk factors for lung cancer in US veterans with HIV: a longitudinal cohort study (01-03-2017)
Dr. José Ramón Blanco. Investigador de la Unidad de VIH y Alteraciones Metabólicas Asociadas. Centro de investigación Biomédica de La Rioja
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention (15-02-2017)
Dra. Marisa Montes. Unidad de enfermedades infecciosas. Hospital Universitario de la Paz. Madrid
Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4) (01-02-2017)
Dr. Javier de la Torre Lima. Servicio de Medicina Interna. Hospital Costa del Sol. Marbella
Impact of the Centers for Disease Control’s HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States (16-01-2017)
Dra. Concha Amador. Médico de Enfermedades Infecciosas. Hospital Villajoyosa de Alicante
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial (02-01-2017)
Dr. José A. Pérez Molina. Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients A Cohort Study (15-12-2016)
Dr. Adrian Currán. Atencion sanitaria y hospitalaria. Hospital Universitari de la Vall d´Hebron.
Suboptimal cART Adherence is Associated with Higher Levels of Inflammation Despite HIV Suppression (01-12-2016)
Dr. José Ramón Blanco. Investigador de la Unidad de VIH y Alteraciones Metabólicas Asociadas. Centro de investigación Biomédica de La Rioja
Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis (17-11-2016)
Dra. Marisa Montes. Unidad de enfermedades infecciosas. Hospital Universitario de la Paz. Madrid
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years After Starting Antiretroviral Therapy (28-10-2016)
Dr. Javier de la Torre Lima. Servicio de Medicina Interna. Hospital Costa del Sol. Marbella
Antiretroviral Therapy for Prevention of HIV-1 Transmission (17-10-2016)
Dra. Concha Amador Prous. Médico de Enfermedades Infecciosas. Hospital Villajoyosa de Alicante
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. ESTUDIO PARTNER (30-09-2016)
Dr. José A. Pérez Molina. Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal. Madrid
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: Implications for timing of therapy (15-06-2016)
Dr. Antonio Rivero. Jefe de sección de Enfermedades Infecciosas. Hospital Universitario Reina Sofía. Córdoba
Non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted proteaseinhibitor-based regimens for initial treatment of HIV infection: A systematic review andmeta-analysis of randomised trials (01-06-2016)
Dr. Federico Pulido. Unidad de Infección VIH. Hospital 12 de Octubre. Madrid
